Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$46.84 - $59.75 $749 - $956
16 Added 0.37%
4,319 $212,000
Q1 2022

Apr 27, 2022

SELL
$48.09 - $57.79 $1,250 - $1,502
-26 Reduced 0.6%
4,303 $244,000
Q4 2021

Feb 11, 2022

BUY
$47.19 - $62.68 $1,085 - $1,441
23 Added 0.53%
4,329 $227,000
Q3 2021

Nov 12, 2021

BUY
$56.91 - $67.81 $626 - $745
11 Added 0.26%
4,306 $258,000
Q1 2020

Apr 29, 2020

BUY
$32.82 - $81.13 $1,476 - $3,650
45 Added 1.06%
4,295 $218,000
Q3 2019

Nov 08, 2019

SELL
$55.78 - $68.08 $9,761 - $11,914
-175 Reduced 3.95%
4,250 $269,000
Q2 2019

Jul 24, 2019

SELL
$53.69 - $65.47 $536 - $654
-10 Reduced 0.23%
4,425 $259,000
Q2 2018

Aug 07, 2018

SELL
$48.15 - $56.68 $24,075 - $28,340
-500 Reduced 10.13%
4,435 $231,000
Q1 2018

Apr 30, 2018

SELL
$46.03 - $61.28 $12,520 - $16,668
-272 Reduced 5.22%
4,935 $258,000
Q4 2017

Feb 08, 2018

BUY
$50.58 - $60.79 $1,112 - $1,337
22 Added 0.42%
5,207 $305,000
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $277,604 - $352,580
5,185
5,185 $288,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.